Parnell Pharmaceuticals (CE) (PARNF)

Parnell Pharmaceuticals Holdings Ltd (CE)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:PARNF

1 2 3 4 Next >>

Date	Time	Source	Headline	Symbol	Company
07/08/2017	20:41	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
03/08/2017	17:15	Edgar (US Regulatory)	Amended Report of Foreign Issuer (6-k/a)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
31/03/2017	14:36	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
21/03/2017	20:18	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
14/02/2017	16:47	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
03/01/2017	17:09	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
03/01/2017	11:01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
03/01/2017	11:01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
21/12/2016	19:51	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
21/12/2016	19:46	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
21/12/2016	19:40	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
21/12/2016	19:37	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
21/12/2016	14:43	Edgar (US Regulatory)	(25)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
19/12/2016	21:31	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
19/12/2016	21:30	GlobeNewswire Inc.	Parnell Pharmaceuticals Holdings Ltd Files Form 25, Voluntarily Delisting Its Shares From NASDAQ	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
09/12/2016	22:01	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
09/12/2016	22:00	GlobeNewswire Inc.	Parnell Pharmaceuticals Holdings Ltd Announces Intention To Move From the NASDAQ OMX Global Market and Expects To Move To the...	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
01/12/2016	12:01	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
30/11/2016	12:01	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
23/11/2016	03:34	GlobeNewswire Inc.	Parnell Pharmaceuticals Holdings Ltd Announces $20 Million Secured Term Loan Facility	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
02/11/2016	20:01	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
02/11/2016	20:00	GlobeNewswire Inc.	Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Nine-Month Period Ended September 30, 2016	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
27/10/2016	20:49	GlobeNewswire Inc.	Parnell to Report Financial Results for the Nine Months Ended September 30, 2016 on November 2, 2016	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
04/08/2016	16:37	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
04/08/2016	12:01	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
04/08/2016	12:00	GlobeNewswire Inc.	Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Six-Month Period Ended June 30, 2016	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
26/07/2016	22:00	GlobeNewswire Inc.	Parnell to Report Financial Results for the Six Months Ended June 30, 2016 on August 4, 2016	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
31/05/2016	21:07	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
31/05/2016	21:07	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)
31/05/2016	21:05	GlobeNewswire Inc.	Parnell Pharmaceuticals Holdings Ltd Announces Contract Manufacturing Agreement with Merial	USOTC:PARNF	Parnell Pharmaceuticals Holdings Ltd (CE)